Recent Articles from GlobeNewswire

EINDHOVEN, the Netherlands, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, today announces the enrollment of the first participant in Empower BP, a global pivotal study assessing the safety and effectiveness of the investigational ARC-IM® System in managing symptomatic blood pressure instability in people with chronic spinal cord injury (SCI).

BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Curium Group today announced that together with PeptiDream Inc. and PDRadiopharma Inc., the first patient has been dosed in the companies’ registrational clinical trial of 177Lu-PSMA-I&T in Japan for patients with PSMA (*1)-positive metastatic castration-resistant prostate cancer (mCRPC).

Press release4 February 2026 - N° 03

Equinor (OSE: EQNR, NYSE: EQNR) will on 5 February 2026 commence the first tranche of up to USD 375 million of the share buy-back programme for 2026, as announced in relation with the company’s fourth quarter results on 4 February 2026.

Key information relating to the proposed cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for fourth quarter 2025.

Equinor (OSE:EQNR, NYSE:EQNR) delivered an adjusted operating income* of USD 6.20 billion and USD 1.55 billion after tax* in the fourth quarter of 2025. Equinor reported a net operating income of USD 5.49 billion and a net income of USD 1.31 billion. Adjusted net income* was USD 2.04 billion, leading to adjusted earnings per share* of USD 0.81.

York, PA, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ATC Pest Control, a family-operated pest management company serving Pennsylvania and Maryland since 1991, has introduced a bed bug treatment system that combines controlled heat with humidity regulation to improve the effectiveness of thermal remediation. The approach is designed to address growing concerns around chemical resistance in bed bug populations while providing a non-chemical treatment option for residential environments.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Klarna Group plc (“Klarna” or the “Company”) (NYSE: KLAR) of a class action securities lawsuit.

NEW YORK CITY and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in CoreWeave, Inc. (“CoreWeave” or the “Company”) (NasdaqGS: CRWV) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Washington.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK CITY and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Coupang, Inc. (“Coupang” or the “Company”) (NYSE: CPNG) of class action securities lawsuits.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 23, 2026 to file lead plaintiff applications in a securities class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR), if they purchased or otherwise acquired the Company’s securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK and NEW ORLEANS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.

LEXINGTON, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics (Nasdaq: INKT) today announced that new translational data supporting the role of invariant natural killer T (iNKT) cells in idiopathic pulmonary fibrosis (IPF) were presented at the Emerging Cell Therapies Meeting of the Keystone Symposia on Molecular and Cellular Biology, taking place February 1–4, 2026, in Banff, Alberta, Canada.

DALLAS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The March/April print edition of SUCCESS® has officially arrived at newsstands, centered on the theme of Intelligence. Headlined by actress and neuroscientist Mayim Bialik, this issue moves beyond theory to offer readers a tactical look at mental wellness, professional innovation and cognitive edge. It is designed for the modern achiever who views lifelong learning as their most valuable asset.

Harford County, MD, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Maryland Windows and Doors, a family-owned window and door replacement company serving Greater Baltimore for more than 45 years, has announced the expansion of its service capacity to meet rising homeowner demand for energy-efficient window replacements. The expanded capacity will support faster scheduling, faster installation availability, and homeowner education as more Maryland households look for practical ways to manage winter heating costs.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In F5 To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Wealthfront To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fermi To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gauzy To Contact Him Directly To Discuss Their Options

New York, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Colombier Acquisition Corp. III (the “Company,” “Colombier III”) today announced the pricing of its initial public offering of 26,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “CLBR U” beginning on February 4, 2026. Each unit consists of one Class A ordinary share and one-eighth of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “CLBR” and “CLBR WS,” respectively.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options

All amounts are in United States dollars, unless otherwise stated

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SLM To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Klarna To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Ramaco To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options

Framework Agreement Identifies Focus Areas for Cooperation in Research, Education, and Innovation

37604, Feb. 03, 2026 (GLOBE NEWSWIRE) -- JOHNSON CITY, Tenn. – Ballad Health announced Mike Anderes, FACHE, as managing director of Ballad Ventures. Anderes has relocated to Northeast Tennessee, bringing 30 years of experience in healthcare innovation, digital transformation and system strategy to support Ballad Health’s mission to improve health in the Appalachian Highlands.

Houston, TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- This is a monumental moment for veteran services. Combined Arms is honored to support bipartisan legislation to create a National Veterans Strategy.

Changing pharmacy payment model must protect patients, pharmacies, NCPA says

Washington, DC, Feb. 03, 2026 (GLOBE NEWSWIRE) -- National Association of Specialty Pharmacy (NASP) President and CEO Sheila Arquette, R.Ph. and Chairman of the Board Scott Guisinger issued a statement today as President Trump signed into law legislation to fund the majority of government programs and for the first time enact pharmacy benefit manager (PBM) reforms aimed at protecting specialty pharmacies and their patients.

Veteran health care finance leader Adrienne Moore to drive strategic vision and growth for nonprofit health system

PHILADELPHIA, Pa., Feb. 03, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC advises shareholders of Stride, Inc. (NYSE: LRN) (“Stride” or the “Company”) about an investigation into Stride’s Board of Directors (the “Board”) for potential breaches of fiduciary duties owed to the Company and its shareholders, including whether the Board failed to exercise appropriate oversight and governance in connection with the Company’s and its executives’ public statements regarding Stride’s operations and financial performance.

RONKONKOMA, N.Y., Feb. 03, 2026 (GLOBE NEWSWIRE) -- SUNation Energy Inc. (Nasdaq: SUNE) (“SUNation” or the “Company”), a leading provider of sustainable solar energy and backup power solutions to residential, commercial, and municipal customers, today announced that it has eliminated the remainder of approximately $1.1M (of an original $2.5m) and substantially reduced its monthly repayments related to a long-term debt obligation of its wholly-owned subsidiary SUNation Solar Systems, significantly improving ongoing cash flow and strengthening the Company’s balance sheet.

Exhibit 99.1

WEST PALM BEACH, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Solitron Devices, Inc. (OTC Pink: SODI) (“Solitron” or the “Company”) is announcing that the Company’s Board of Directors has set April 24, 2026 as its annual meeting date and has decided to pursue the exploration of potential transactions including merger or sale opportunities.  

MELBOURNE, Australia and INDIANAPOLIS, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that it will release its full year results for the period ended 31 December 2025 on Friday, 20 February 2026 AEDT (Thursday, 19 February 2026 EST).

First Quarter 2026 Diluted earnings per share (“EPS”) of $1.37 and Adjusted EPS of $1.53

WOODLAND PARK, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) announced today that it will hold a conference call on Thursday, February 12, 2026, at 9:00 a.m. ET. Anterix senior management, led by President and CEO Scott Lang, will discuss the Company’s third quarter fiscal 2026 results. A press release regarding the results will be issued after the close of the market on Wednesday, February 11, 2026.Participants interested in joining the call’s live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended that you join the call at least 10 minutes before the conference call begins. The call is also being webcast live and will be accessible on the Investor Relations section of Anterix’s website at https://investors.anterix.com/events-presentations. Following the event, a replay of the call will also be available on the Anterix website.

*Non-GAAP - refer to the section titled Non-GAAP Financial Measures Defined and GAAP to Non-GAAP Financial Measures Reconciled HOUSTON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) announced today its results for the fourth quarter of 2025 and full year 2025.

MENLO Park, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (“Runway Growth” or the “Company”) (Nasdaq: RWAY), today announced that it intends to redeem a portion of its 7.50% Notes due 2027 (CUSIP No. 78163D 209; NasdaqGS: RWAYL) (the “7.50% Notes”) and all of its 8.00% Notes due 2027 (CUSIP No. 78163D 308; NasdaqGS: RWAYZ) (the “8.00% Notes”, together with the 7.50% Notes, the “Notes”). The Company expects to redeem $40,250,000 aggregate principal amount of the issued and outstanding 7.50% Notes on March 5, 2026 and $51,750,000 aggregate principal amount of the issued and outstanding 8.00% Notes on March 5, 2026 (the “Redemption Date”). The redemption price per Note will be $25 plus accrued and unpaid interest thereon from March 1, 2026 to, but not including, the Redemption Date.

SAN FRANCISCO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company granted stock options to two new employees to purchase an aggregate of 24,000 shares of the Company's common stock, effective as of February 2, 2026. These awards were approved by the Compensation Committee of Olema’s Board of Directors and granted under the Company's 2022 Inducement Plan as an inducement material to the new employees entering into employment with Olema, in accordance with Nasdaq Listing Rule 5635(c)(4).

LATHAM, N.Y., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that it will release financial results for the fourth quarter and full year 2025 on Tuesday, March 3, 2026, after the close of the U.S. market. The Company will hold a conference call to discuss the results that same day at 4:30 PM Eastern Time.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CoreWeave (CRWV) To Contact Him Directly To Discuss Their Options

GAAP Net Income of $177 million, or $1.22 per diluted shareAdjusted Operating Income of $179 million, or $1.23 per diluted shareReturn on Equity of 13.3% and Adjusted Operating Return on Equity of 13.5%Primary Insurance in-force of $273 billion, a 2% year-over-year increasePMIERs Sufficiency of 162% or approximately $1.9 billionBook Value Per Share of $37.66 and Book Value Per Share excluding AOCI of $37.87Returned over $500 million of capital to shareholders in 2025

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Varonis (VRNS) To Contact Him Directly To Discuss Their Options

MILWAUKEE, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) (the “Company” or “Artisan Partners”) today reported its results for the quarter and year ended December 31, 2025 and declared a quarterly and special annual dividend. The full earnings release and investor presentation can be viewed at www.apam.com.

FY'25 Net Revenues +5.8%, Organic Net Revenues1 +4.3%, Volume/Mix -3.7%

SANTA CLARA, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced financial results for the fourth quarter and full year of 2025. Fourth quarter revenue was a record $10.3 billion, gross margin was 54%, operating income was $1.8 billion, net income was $1.5 billion and diluted earnings per share was $0.92. On a non-GAAP(*) basis, gross margin was 57%, operating income was a record $2.9 billion, net income was a record $2.5 billion and diluted earnings per share was a record $1.53.

ATLANTA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” the “Company,” “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced that its Board of Directors approved a quarterly dividend of $0.476563 per share to Series B Cumulative Perpetual Preferred shareholders. The cash dividend will be paid on or about March 16, 2026 to holders of record of Atlanticus’ Series B Cumulative Perpetual Preferred Stock on the close of business on March 1, 2026.

SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE: AAT) (the “company”) today reported financial results for its fourth quarter and year ended December 31, 2025.

RALEIGH, N.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors authorized a new share repurchase program under which the company may purchase up to $500 million of its common stock. The new share repurchase authorization is in addition to the company’s current $350 million share repurchase program, of which $30 million remains as of January 30, 2026.

Atlanta, GA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Piedmont Realty Trust (the “Company” or “Piedmont”) (NYSE: PDM) announced today that it has promoted Alex Valente to Co- Chief Operating Officer, working alongside George M. Wells, to oversee all property management and asset management areas of the Company. Mr. Valente, who has most recently served as Executive Vice-President of Piedmont’s Southeast Region, has been with the Company for almost 20 years and has been responsible for leasing, asset management, construction, and redevelopment activities for numerous assets throughout the Company’s portfolio during his tenure, including negotiating leases with some of the Company’s largest tenants. In his new role, Mr. Valente will lead new operational initiatives across the firm as well as oversee substantially all of the Company’s Eastern portfolio comprised of approximately nine million square feet located in Atlanta, Orlando, Northern Virginia/DC, and Boston.

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) --

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Charming (MCTA) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Richtech (RR) To Contact Him Directly To Discuss Their Options

Washington, D.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- The Thurgood Marshall College Fund (TMCF) extends its gratitude to Speaker of the House Mike Johnson (R-LA), Senate Majority Leader John Thune (R-SD), House Minority Leader Hakeem Jeffries (D-NY), Senate Minority Leader Chuck Schumer (D-NY), House Appropriations Committee Chair Tom Cole (R-OK), Senate Appropriations Chair Susan Collins (R-ME), House Appropriations Committee Ranking Member Rosa DeLauro (D-CT) and Senate Appropriations Committee Vice-Chair Patty Murray (D-WA) for their leadership in ensuring the passage of the FY26 minibus appropriations bill that included Departments of Labor, Health and Human Services, and Education, and related agencies (Labor-H) appropriations.

DENVER, Feb. 03, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025.

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adamas Trust, Inc. (Nasdaq: ADAM) (the “Company”) is scheduled to report financial results for the three and twelve months ended December 31, 2025 after the close of market on February 18, 2026. Adamas Trust’s executive management will host a conference call and audio webcast at 9:00 a.m., Eastern Time, on Thursday, February 19, 2026. To access the conference call, please pre-register using this link. Registrants will receive confirmation with dial-in details.

SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on February 1, 2026, the Company granted to one newly-hired non-executive employee (i) non-qualified stock options to purchase a total of 120,000 shares of the Company’s common stock at an exercise price per share of $1.19, which was the closing price per share of the Company’s common stock as reported by NASDAQ on January 30, 2026, and (ii) restricted stock units (RSUs) representing 90,000 shares of its common stock. The grants were approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employee entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% vesting in approximately equal monthly installments over the following thirty-six months, subject to the employee being continuously employed by the Company through each vesting date. The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employee being continuously employed by the Company through each vesting date.

CORNELIUS, N.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Alpha Modus Financial Services (“AMFS”), a division of  Alpha Modus Holdings, Inc. (“Alpha Modus”) (NASDAQ: AMOD), has entered into a multi-year services agreement with ACI Worldwide (“ACI”) (NASDAQ: ACIW), a global leader in mission-critical real-time payments software, to support remittance and bill payment capabilities across the Alpha Cash ecosystem.

LOUISVILLE, Ky., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its fourth quarter and full year 2025 financial results on Friday, February 27, 2026, prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day.

TA KHMAU, Cambodia, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Kandal M Venture Limited (Nasdaq: FMFC) (“Kandal” or the “Company”), a contract manufacturer of affordable luxury leather goods with manufacturing operations in Cambodia, today announced the appointment of Mr. Fok Yui Kwong as Executive Director and Chief Executive Officer, effective February 1, 2026.

JERSEY CITY, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- AvePoint (NASDAQ: AVPT; SGX: AVP), the global leader in AI data protection, unifying data security, governance, and resilience, will report its fourth quarter and full year 2025 financial results after the US financial markets close on Thursday, February 26, 2026.

IRVINE, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions for numerous applications, today reported first fiscal quarter results for the period ended Jan. 2, 2026.

All dollar references are in U.S. dollars, unless noted otherwise.